<DOC>
	<DOCNO>NCT00003705</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase I trial study effectiveness BMS-184476 treating patient advance solid tumor .</brief_summary>
	<brief_title>BMS-184476 Treating Patients With Advanced Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : I . Determine maximum tolerate dose , dose limit toxicity , recommend phase II dose , safety BMS-184476 patient advance solid tumor . II . Determine pharmacokinetic profile BMS-184476 metabolites patient . III . Determine preliminary evidence antitumor activity BMS-184476 patient . OUTLINE : This open label , dose escalation study . Patients receive BMS-184476 IV 1 hour . Treatment repeat every 21 day absence disease progression unacceptable toxicity . In second part study , patient receive BMS-184476 IV 1 hour weekly . Cohorts 3-6 patient treat escalate dos BMS-184476 . The maximum tolerate dose define dose few 2 6 patient experience dose limit toxicity . Patients follow every 4 week toxicity resolve . PROJECTED ACCRUAL : A total 20-40 patient accrue study within 12-18 month .</detailed_description>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm advanced solid tumor refractory conventional anticancer therapy , effective therapy exist Measurable evaluable disease No active brain metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : At least 3 month Hematopoietic : Absolute neutrophil count least 2,000/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 1.5 mg/dL ALT AST great 2.5 time upper limit normal ( ULN ) Renal : Creatinine le 1.5 time ULN Cardiovascular : No uncontrolled significant cardiovascular disease No myocardial infarction within past 6 month No congestive heart failure ( without therapy ) No history atrial ventricular arrhythmia No history second third degree heart block Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No serious uncontrolled medical disorder active infection No know hypersensitivity drug contain Cremophor EL No concurrent neurologic toxicity No dementia alter mental status PRIOR CONCURRENT THERAPY : Biologic therapy : At least 4 week since prior immunotherapy Chemotherapy : At least 4 week since prior chemotherapy ( 6 week since nitrosoureas , mitomycin , carboplatin ) Prior taxane therapy allow No concurrent chemotherapy Endocrine therapy : At least 1 week since prior steroid therapy No concurrent hormonal therapy Radiotherapy : At least 4 week since prior wide field radiotherapy ( involve least 30 % bone marrow ) No concurrent radiotherapy Surgery : Not specify Other : No concurrent experimental anticancer medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>